Correction to “The Angiotensin IV Analog Nle-Tyr-Leu-ψ-(CH₂-NH₂)^3-4-His-Pro-Phe (Norleual) Can Act as a Hepatocyte Growth Factor/c-Met Inhibitor”

In the above article [Yamamoto BJ, Elias PD, Masino JA, Hudson BD, McCoy AT, Anderson ZJ, Varnum MD, Sardinia MF, Wright JW, and Harding JW (2010) J Pharmacol Exp Ther 333:161–173], an error is present in the Abstract.

The peptide reported in the article, Norleual, is referred to as Nle-Tyr-Leu-ψ-(CH₂-NH₂)^3-4-His-Pro-Phe in the article title, abbreviations, and main body; however, in the Abstract, the peptide is incorrectly referred to as Nle-Tyr-Ile-ψ-(CH₂-NH₂)^3-4-His-Pro-Phe.

The Abstract is corrected with the issue of this erratum.

The society regrets this error and any inconvenience it may have caused.